Novartis AG (NVSEF) stock
NVSEFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as NVS
$146.46+2.56 (+1.78%)
Close on Oct 19, 2026Market cap $279.46BP/E 20.5Yield –
Novartis shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Novartis's shares outstanding was 1.91B at Jun 30, 2026. For fiscal 2025 it was 1.96B, down 3.9% from the year before. Over ten years it grew -2.2% a year on average. The highest annual figure on record is 2.44B in fiscal 2015.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1.96B | -3.9% |
| FY2024 | Dec 31, 2024 | 2.04B | -2.7% |
| FY2023 | Dec 31, 2023 | 2.09B | -4.8% |
| FY2022 | Dec 31, 2022 | 2.20B | -2.8% |
| FY2021 | Dec 31, 2021 | 2.26B | -1.6% |
| FY2020 | Dec 31, 2020 | 2.30B | -1.0% |
| FY2019 | Dec 31, 2019 | 2.32B | -1.1% |
| FY2018 | Dec 31, 2018 | 2.34B | -1.1% |
| FY2017 | Dec 31, 2017 | 2.37B | -1.2% |
| FY2016 | Dec 31, 2016 | 2.40B | -1.6% |
| FY2015 | Dec 31, 2015 | 2.44B | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 1.91B | -13.4% |
| Q2 FY2025 | Jun 30, 2025 | 1.96B | -13.2% |
| Q2 FY2024 | Jun 30, 2024 | 2.05B | -11.2% |
| Q2 FY2023 | Jun 30, 2023 | 2.10B | -10.2% |
| Q2 FY2022 | Jun 30, 2022 | 2.21B | -5.8% |
| Q2 FY2021 | Jun 30, 2021 | 2.26B | -4.8% |
| Q2 FY2020 | Jun 30, 2020 | 2.30B | – |
| Q2 FY2019 | Jun 30, 2019 | 2.33B | – |
| Q2 FY2018 | Jun 30, 2018 | 2.35B | – |
| Q2 FY2017 | Jun 30, 2017 | 2.37B | – |
See a number that looks wrong?